Synthesis process of quinoline medical intermediate

A synthesis process and intermediate technology, which is applied in the field of synthesis process of quinoline series pharmaceutical intermediates, which can solve the problems of scorched products, high temperature, and isomers.

Pending Publication Date: 2021-06-08
南京波普生物医药研发有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There are not many manufacturers of quinoline series products in the market. One of the main problems is that the process of closing the ring requires a very high temperature. In the actual scale-up process, many factories consider safety factors and generally do not choose to carry out the temperature above 200 degrees. Synthetic operation, and the conventional solvents are high boiling point solvents such as diphenyl ether and biphenyl eutectic. In use, the temperature needs to be heated to 250 degrees Celsius to achieve ring closure. Usually, due to excessive temperature, some products will decompose or have isomerization The production of bodies requires special equipment in the mass production process to facilitate operation
The product of the ring closure step is charred and difficult to purify

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis process of quinoline medical intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1: The present invention provides a synthesis process of quinoline series pharmaceutical intermediates. Step 1: When the room temperature is 20°C, dissolve 8kg of SM in 56L of ethanol, add 8.5kg of ethyl acetoacetate, and add 12.5kg of anhydrous magnesium sulfate , add 280mL of acetic acid, heat up to reflux at 80°C-85°C, and finish the reaction after 18 hours of reaction;

[0020] Step 2: Cool the solution to room temperature, filter, drain the filter cake, rinse with ethanol, and concentrate the filtrate to dryness to obtain a reddish-brown liquid;

[0021] Step 3: When the red-brown liquid in step 2 is heated up to 70°C, pour 75% sulfuric acid into a 50L reaction kettle, and when the temperature rises to 80°C, slowly drop 8kgSM into the reaction bottle;

[0022] Step 4: Stir for 30 minutes after the addition is complete, detect that there is no raw material, add 10L of water dropwise, and then process after the addition;

[0023] Step 5: Cool the solution...

Embodiment 2

[0028] Embodiment 2: The present invention provides a quinoline series pharmaceutical intermediate synthesis process, step 1: when the room temperature is 20°C, dissolve 7kgSM in 56L ethanol, add 7.5kg ethyl acetoacetate, add 11.5kg anhydrous magnesium sulfate , add 250mL acetic acid, heat up to reflux at 75°C-85°C, and finish the reaction after 16 hours of reaction;

[0029] Step 2: Cool the solution to room temperature, filter, drain the filter cake, rinse with ethanol, and concentrate the filtrate to dryness to obtain a reddish-brown liquid;

[0030] Step 3: When the reddish-brown liquid in step 2 is heated up to 60°C, pour 65% sulfuric acid into a 50L reaction kettle, and when the temperature rises to 70°C, slowly drop 7kgSM into the reaction flask;

[0031] Step 4: Stir for 30 minutes after the addition is complete, detect that there is no raw material, add 10L of water dropwise, and then process after the addition;

[0032] Step 5: Cool the solution to room temperature ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synthesis process of a quinoline medical intermediate. The method comprises the following steps: step 1, when the room temperature is 20 DEG C, dissolving SM in ethanol, adding ethyl acetoacetate, anhydrous magnesium sulfate and L acetic acid, and ending the reaction after 18 hours; step 2, cooling the solution to room temperature, performing filtering, draining a filter cake, performing leaching with ethanol, and concentrating the filtrate to be dry to obtain a reddish brown liquid; step 3, when the temperature of the reddish brown liquid in the step 2 is raised to 70 DEG C, pouring 75% sulfuric acid into a 50L reaction kettle, and when raising the temperature to 80 DEG C, slowly dropping SM into a reaction bottle; step 4, performing stirring for 30 minutes after the addition is finished, dropwise adding 10 L of water when no raw materials are detected, and performing treatment after the addition is finished; and step 5, cooling the solution to the room temperature, then adding 10 L of water, and adjusting the pH value of the solution to 7-8. According to the synthesis process of the quinoline medical intermediate, operation simplification is achieved, ring closing operation can be directly conducted under the condition of crude products in the first-step reaction, the yield is not affected, the solvent is simple and cheap, and operation is convenient.

Description

technical field [0001] The invention relates to a synthesis method of quinoline, in particular to a synthesis process of quinoline series pharmaceutical intermediates, and belongs to the technical field of quinoline synthesis. Background technique [0002] Quinoline, also known as benzopyridine and azine, is a heterocyclic aromatic organic compound and a colorless hygroscopic liquid with a strong odor. Its molecular formula is C9H7N. Exposing quinoline to light will slowly turn pale yellow and further brown. Quinoline is slightly soluble in water, but readily soluble in many organic solvents. Quinoline is an important intermediate in metallurgy, dyestuff, polymer and agrochemical industries. It can also be used as a disinfectant, preservative and solvent. [0003] There are not many manufacturers of quinoline series products in the market. One of the main problems is that the process of closing the ring requires a very high temperature. In the actual scale-up process, many...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D215/233
CPCC07D215/233
Inventor 胡松源问峻韬郑斌斌陈志超
Owner 南京波普生物医药研发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products